Therapy News and Research

RSS

VDF honors physicians, leaders in the field of vascular disease with President's Awards

The Vascular Disease Foundation (VDF) presented its annual awards at the organization's eighth annual meeting in Washington. The awards honor the work of citizens, health care providers, organizations, researchers and companies that have enhanced the understanding and/or treatment of peripheral vascular diseases.

26 Sep 2011

University of Utah develops video game to help children with cancer

Even super heroes need a chance to get better, especially if they've been fighting their arch-nemesis and a robotic crab that just won't go away. At least, that's the premise behind a video game developed at the University of Utah to help children with cancer during their treatment.

26 Sep 2011

Combination of everolimus, exemestane holds promise against post-menopausal breast cancer

Results from a phase III clinical trial have shown that combining two existing cancer drugs to treat post-menopausal women with advanced breast cancer resistant to hormonal therapy significantly improves outcome.

26 Sep 2011

Janssen Biotech receives FDA approval for Remicade to treat UC in children

The U.S. Food and Drug Administration today approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

26 Sep 2011

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal women

Results from the longest-running trial comparing tamoxifen with the aromatase inhibitor letrozole show unequivocally that letrozole has withstood the test of time and continues to prevent breast cancer recurrences and reduce the risk of death in post-menopausal women with hormone receptor-positive early breast cancer.

26 Sep 2011

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

The U.S. Food and Drug Administration today approved Soliris (eculizumab) to treat patients with atypical Hemolytic Uremic Syndrome (aHUS), a rare and chronic blood disease that can lead to kidney (renal) failure and is also associated with increased risk of death and stroke.

26 Sep 2011

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

Gilead Sciences, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion on the company's Marketing Authorisation Application for the once-daily single-tablet regimen, Eviplera.

23 Sep 2011

Role of email advice in patients with sexual problems

More than two-thirds of men who contacted an email advice service run by a leading sexual advice charity had erection problems, which were frequently linked to loss of sex drive, according to research in the October issue of IJCP, the International Journal of Clinical Practice.

23 Sep 2011

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

Celgene International Sàrl was notified today that the E.U. Committee for Medicinal Products for Human Use (CHMP), on behalf of the European Medicines Agency (EMA) has concluded an Article 20 review of REVLIMID and issued a positive opinion for the use of REVLIMID in combination with dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

23 Sep 2011

National HIV/AIDS Strategy meeting to be held at UAB

The White House Office of National AIDS Policy is holding a series of National HIV/AIDS Strategy Implementation Dialogues across the country to examine critical issues and encourage action and collaboration at the state and local levels. The first meeting, focusing on incorporating prevention and care research into HIV programs, is being held at the University of Alabama at Birmingham on Tuesday, Sept. 27, 2011.

23 Sep 2011

USF receives U.S. Department of Defense award for musculoskeletal research

The University of South Florida School of Physical Therapy & Rehabilitation Sciences has received a $1.59-million U.S. Department of Defense award for leading-edge musculoskeletal research intended to benefit active duty soldiers and veterans and improve military preparedness.

23 Sep 2011

Two TGen students receive SRP grants for antibiotic resistance and Alzheimer's research

Two Arizona university graduate students working at the Translational Genomics Research Institute (TGen) have each received $50,000 grants from the Salt River Project.

23 Sep 2011

Lawmakers explore savings potential of Medicare extenders

During a Wednesday House Ways and Means Committee hearing, health industry witnesses defended the Medicare "extenders," which, in many cases, are payment policies enacted to address specific problems faced by specific types of health care providers. Ending some of them would save less than $100 million a year. One economist said, however, that when added up, they can tally an estimated $2.5 billion in savings.

23 Sep 2011

Soy protein reduces progression of atherosclerosis in women within 5 years of menopause

A new study published in the November 2011 issue of Stroke reveals some promising data on the positive effects of soy protein reducing the progression of clogged arteries in women who were within five years of menopause. This study was the largest and longest randomized controlled human study conducted to-date that directly investigated the efficacy of isolated soy protein consumption on the progression of atherosclerosis.

23 Sep 2011

UCLA's gene-based imaging system can accurately detect metastatic prostate cancers

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a way to image the spread of a particularly dangerous form of prostate cancer earlier than conventional imaging in use today, which may allow oncologists to find and treat these metastases more quickly and give patients a better chance at survival.

23 Sep 2011

Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore

Adamis Pharmaceuticals Corporation, today announced the technology which constitutes its compound APC-200 was recently granted patents in Singapore and South Africa. These patents significantly strengthen the Adamis APC-200 patent portfolio for the use of APC-200 in the treatment of early and late stage prostate cancer.

23 Sep 2011

Low levels of vitamin D associated with poorer lung function in children with STRA

Children with severe therapy-resistant asthma (STRA) may have poorer lung function and worse symptoms compared to children with moderate asthma, due to lower levels of vitamin D in their blood, according to researchers in London.

23 Sep 2011

Study: Opioid drugs can increase risk of pneumonia in older adults

Opioids -- a class of medicines commonly given for pain -- were associated with a higher risk of pneumonia in a study of 3,061 adults, aged 65 to 94, e-published in advance of publication in the Journal of the American Geriatrics Society.

23 Sep 2011

Study helps predict which ARVD patients are at highest risk of sudden cardiac death

...

22 Sep 2011

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1.5 million from the Foundation Fighting Blindness to fund a pre-clinical trial evaluating the safety and efficacy of a gene therapy treatment for X-linked Retinoschisis (XLRS), a genetic eye disease affecting over 35,000 patients in the US and Europe.

22 Sep 2011

Therapy News and Research

VDF honors physicians, leaders in the field of vascular disease with President's Awards

University of Utah develops video game to help children with cancer

Combination of everolimus, exemestane holds promise against post-menopausal breast cancer

Janssen Biotech receives FDA approval for Remicade to treat UC in children

Letrozole reduces risk of breast cancer recurrences and death in post-menopausal women

Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome

Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera

Role of email advice in patients with sexual problems

E.U. CHMP issues positive opinion for use of Celgene's REVLIMID/dexamethasone MM drug

National HIV/AIDS Strategy meeting to be held at UAB

USF receives U.S. Department of Defense award for musculoskeletal research

Two TGen students receive SRP grants for antibiotic resistance and Alzheimer's research

Lawmakers explore savings potential of Medicare extenders

Soy protein reduces progression of atherosclerosis in women within 5 years of menopause

UCLA's gene-based imaging system can accurately detect metastatic prostate cancers

Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore

Low levels of vitamin D associated with poorer lung function in children with STRA

Study: Opioid drugs can increase risk of pneumonia in older adults

Study helps predict which ARVD patients are at highest risk of sudden cardiac death

AGTC receives FFB grant to evaluate gene therapy treatment for X-linked Retinoschisis

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News